Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 13,186

Document Document Title
WO/2015/185676A1
The present invention relates to an apparatus and method for separating glycoglycerolipids and also glycoglycerolipids and glycosphingolipids from a lipid phase that contains glycoglycerolipids and acyl glycerides or glycoglycerolipids a...  
WO/2015/184451A1
Truncated triterpene saponin analogues containing a trisaccharide or tetrasaccharide ester are disclosed. Also disclosed are pharmaceutical compositions comprising truncated saponin analogues and synthetic methods of producing the trunca...  
WO/2015/177668A1
Compounds of Formula (A) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by pharmaceutical compositions and the uses thereof as asialoglycoprotein receptor (ASGPR) targeting a...  
WO/2015/003082A3
The present invention includes novel chemical formulations having antimicrobial activity and their methods of use thereof. In some embodiments, the formulation further comprises at least one fungus.  
WO/2015/178265A1
It was discovered that interposing a suitable aromatic amidation linker in making a prodrug to serve as a γ-glutamylation drug provides stability even in a close to physiological environment, recognition by GGT, and very rapid release o...  
WO/2015/168779A1
A method for purifying Mogroside V comprises passing a solution of a pre-prepared Siraitia grosvenori primary extract through a multi-column system including a plurality of columns, in series, packed with a porous adsorbent resin to prov...  
WO/2015/171944A1
The present invention provides edible compositions comprising a compound of the present invention, food products comprising such edible compositions and methods of preparing such food products. The present invention also provides methods...  
WO/2015/171555A1
Disclosed is a steviol glycoside referred to as rebaudioside D2. Rebaudioside D2 has five β-D-glucosyl units connected to the aglycone steviol. Also disclosed are methods for producing rebaudioside D2, a UDP-glycosyltransferase fusion e...  
WO/2015/166016A1
The present invention relates to a method for purifying epidaunorubicin, in particular to the removal of the impurity epi-feudomycin such as is formed as a by-product in the biotechnological production of epidaunorubicin.  
WO/2015/168514A1
Provided herein are improved methods for the synthesis of reactive conjugate clusters and intermediates used in such methods. In particular, improvements are provided that enhance the synthesis of reactive conjugate clusters by reducing ...  
WO/2015/158575A1
Calixarene compound according to formula (I) wherein: R1 represents a linear or branched C(1-16) alkyl group; R2 represents an hydrogen atom or a methyl group; R3 is identical to R1 or R2 group; R4 represents a saccharide residue, in whi...  
WO/2015/158206A1
A C-aryl indican derivative represented by formula (I), and a pharmaceutical composition thereof and a preparation method therefor, as well as uses of the C-aryl indican derivative and a pharmaceutically acceptable salt or pharmaceutical...  
WO/2015/152707A1
Various ingredients and compositions are prepared from Stevia rebaudiana Bertoni plant. The compositions can be used as bulking agents, and sweeteners in foods, beverages, cosmetics and pharmaceuticals.  
WO/2015/154074A1
A method is disclosed for synthesizing a compound that includes gallotannins from a part of a maple tree, into new skin whitening compounds. The method includes the step of isolating the gallotannin from the part of the maple tree.  
WO/2015/144731A1
The invention relates to a method for producing derivatives of O-α-glucosylated flavonoid, comprising at least one step of incubating a glucansucrase with a flavonoid and at least one sucrose, the flavonoid being a flavonoid which is mo...  
WO/2015/140178A1
The present invention relates to a compound of the following formula (I): in which at least one and only one group chosen among R5, R6 and R7 is a group of the following formula: The present invention relates also to uses thereof for pre...  
WO/2015/136027A1
The invention relates to carbohydrate ligands presenting the minimal Human Natural Killer-1 (HNK-1) epitope that bind to anti-MAG (myelin-associated glycoprotein) IgM antibodies, and their use in diagnosis as well as for the treatment of...  
WO/2015/137838A1
A compound of formula I : or a salt thereof, wherein: R1 is -OC(H) (X) (CH2)nC(=O)OH; R2 is -OH, -N3, or -N (H) C (=O) CH3; or R1 and R2 together with the carbon atoms to which they are attached form R3 is -H, -CH3, -CH2C(=O)OH, or -CH2O...  
WO/2015/132577A1
The invention relates to compounds for use in the modification of compounds comprising nucleic acid sequences (such as oligonucleotides or the like), to modified oligonucleotides, to the delivery of modified oligonucleotides to cells and...  
WO/2015/128797A1
The present invention relates to synthesis of novel higher oligomers and process of preparing the same. In particular the present invention relates to the chemical synthesis of oligomers of Neisseria meningitidis serogroup X ('hereinafte...  
WO/2015/128344A1
Sialic acid derivatives of the formula (I) in which the symbols have the meanings given in the description, are suitable as medicaments, in particular for diseases the progression of which is influenced by Siclec ligands.  
WO/2015/126876A1
A comprehensive process for the separation, isolation and characterization of a combination of two or more steviol glycosides from extract of Stevia rebaudiana plants and their use in sweetening compositions are disclosed. Combinations o...  
WO/2015/125781A1
 A method for producing a compound represented by general formula (II) via a step for reacting a compound represented by general formula (I) with a sulfur compound, and a compound. In general formulas (I) and (II), R1 represents a hydr...  
WO/2015/121168A1
The invention relates to a yeast strain and to a method for microbial production of pentacyclic triterpenes and/or triterpenoids in yeast. More particularly, the invention relates to a modified yeast strain for production of pentacyclic ...  
WO/2015/006764A8
Rebaudioside M compositions with improved aqueous solubility and methods for preparing the same are provided herein. The rebaudioside M compositions include (i) disordered crystalline compositions comprising rebaudioside M and rebaudiosi...  
WO/2015/113370A1
Disclosed is a stevioside A glycoside crystal form 7, the structure whereof is represented by the formula I. The X-ray powder diffraction (XRPD) figure of the crystal form 7 has the following characteristic peaks at the angles of 2θ±0....  
WO/2015/113369A1
Disclosed is a stevioside A glycoside crystal form 9, of which the structure is represented by the formula I. The X-ray powder derivative (XRPD) figure of the crystal form 9 has the following characteristic peaks at the angles of 2θ±0....  
WO/2015/101916A1
An improved process for the preparation of empagliflozin is disclosed. Novel intermediates of formulas (13) and (14) for the preparation of empagliflozin are also disclosed, wherein R1 and R2 are independently hydrogen or hydroxyl protec...  
WO/2015/102018A1
This invention relates to Chlorophytum borivilianum, popularly known as Safed Musli. Currently, the active nutrition enhancing ingredients such as Stigmasterol and Hecogenin are extracted from the tuber of the product which is available ...  
WO/2015/019193A3
The present specification is directed to an acylated flavonoid derivative derived from natural or synthetic flavonoids such as phloridzin and isoquercitrin, and long chain fatty acids, mon- or poly- unsaturated once in particular. The ac...  
WO/2015/084846A1
The invention relates to an oligonucleotide including one or more modified nucleoside bases having the structure — B— L— A wherein for each of the modified nucleosides A is independently a monosaccharide or oligosaccharide, L is a ...  
WO/2015/081778A1
The present invention belongs to the field of organic synthesis, relates to a method for synthesizing a saponin, and in particular, to a method for constructing a glycosidic bond in a saponin, and comprises the following steps: directly ...  
WO/2015/085173A1
The invention comprises compounds, methods of making, and methods of using. The compounds may have a linear or cylic backbone and three or four appended functional groups: one or two lipohilic compounds including sterols or "fat soluble"...  
WO/2015/083561A1
The purpose of the present invention is to provide a disaccharide compound which can be optimally used to obtain a modified organopolysiloxane compound having excellent surface-active action. A further purpose is to provide a modified or...  
WO/2015/081438A1
It is provided a multivalent gangloside carbohydrate as a therapeutic cancer vaccine. The GD2 and GD3 carbohydrate conjugated disclosed are linked by a spacer to form a multimer which conserves the native structural feature of naturally ...  
WO/2015/067926A1
Chromogenic substrates for β-D-glucuronidase activity comprising monoglucuronides of some 1,2-dihydroxyaromatic derivatives. When cleaved these form soluble coloured conjugates with multivalent metal ions such as iron ions. The substrat...  
WO/2015/067927A1
Conjugates of 2,3-dihydroxynaphthalene and its derivatives with enzyme cleavable groups are chromogenic substrates that form coloured compounds when complexed with metal ions, e.g. iron ions, on cleavage by enzymes, and are useful in mic...  
WO/2015/051454A1
The present invention relates to nucleotide sequences encoding ent-kaurenoic acid 13- hydroxylase polypeptides and polypeptides having ent-kaurenoic acid 13-hydroxylase activity. The invention also relates to methods of producing steviol...  
WO/2014/115174A8
A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+and/or-) epicatechin and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-pro...  
WO/2015/050240A1
The present invention provides a novel organic acid glycoside that is present in coffee beans and a use thereof. Provided is a compound having a structure represented by formula (1) [in the formula, R1-R7 are each selected independently ...  
WO/2015/043511A1
Disclosed are glucopyranosyl derivatives used as sodium dependent glucose cotransporters (SGLTs) inhibitors, intermediates or preparation processes thereof, and pharmaceutical uses thereof, especially glucopyranosyl derivatives represent...  
WO/2015/046183A1
The purpose of the present invention is to provide a glycoamino acid which is an amino acid precursor having improved properties (particularly solubility in water, stability in water, bitterness, etc.). The present invention relates to a...  
WO/2015/048616A1
Methods for treating and/or preventing mucositis comprising administering to a subject in need thereof an effective amount of at least one compound chosen from E-selectin antagonists, pharmaceutically acceptable salts of E-selectin antag...  
WO/2015/028548A1
Disclosed is tri- or tetravalent sialic acid derivatives comprising a core moiety to which 3 or 4 sialic acid residues are connected via a linker. Such derivatives inhibit the binding of adenovirus to human cells, whereby infections, suc...  
WO/2014/165107A3
The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula (I) The invention also provides processes for making the compounds described herein. Furthermore, the ...  
WO/2015/023928A1
Sweetener compositions including at least 3% Rebaudioside N by weight based on the total weight of sweetener compounds in the sweetener composition are disclosed. The sweetener compositions are used to prepare sweetened compositions incl...  
WO/2015/020114A1
Provided is a novel sophorolipid (SL) that can be applied in a wide range of fields such as beverages, cosmetics, drugs, and quasi-drugs. This sophrolipid compound is represented by formula (I) (in formula (I), R1 represents H or a methy...  
WO/2015/019193A2
The present specification is directed to an acylated flavonoid derivative derived from natural or synthetic flavonoids and fatty acids. The acylated flavonoid derivatives can be part of a pharmaceutical composition. Method of decreasing ...  
WO/2015/020051A1
[Problem] The purpose of the present invention is to provide a method for extracting ceramide and/or pectin, which are useful components, from whole apples and/or apple juice residue. Another purpose of the present invention relating to ...  
WO/2015/014959A1
The present invention relates a process for the recovery of one or more steviol glycosides from a steviol glycoside-containing fermentation broth, which method comprises (a) providing a fermentation broth comprising one or more steviol g...  

Matches 401 - 450 out of 13,186